Increased expression of decorin in experimental hydronephrosis

Kidney International

Volumn 51, Issue 4, 1997, Pages 1133-1139

  Diamond, Jonathan R ^a   Levinson, Mark ^a   Kreisberg, Robert ^a   Ricardo, Sharon D ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DECORIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; HYDRONEPHROSIS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030955016     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1997.156     Document Type: Article

References (28)

1. KLAHR S: Interstitial macrophages. Semin Nephrol 13:488-495, 1993
2. HARRIS KPG, KLAHR S, SCHREINER G: Obstructive nephropathy: From mechanical disturbance to immune activation? Exp Nephrol 1:198-204, 1993
3. DIAMOND JR: Macrophages and progressive renal disease in experimental hydronephrosis. Am J Kid Dis 26:133-140, 1995
4. KANETO H, MORRISSEY J, KLAHR S: Increased expression of TGF-β1 mRNA in the obstructed kidney of rats with unilateral ureteral ligation. Kidney Int 44:313-321, 1993
5. DIAMOND JR, KEES-FOLTS D, DING G, FRYE JE, RESTREPO NC: Macrophages, monocyte chemoattractant peptide-1, and TGF-β1 in experimental hydronephrosis. Am J Physiol 266:F926-F933, 1994
6. PIMENTAL JL, SUNDELL CL, WANG S, KOPP JB, MONTERO A, MARTINEZ-MALDONADO M: Role of angiotensin II in the expression and regulation of transforming growth factor-β in obstructive nephropathy. Kidney Int 48:1233-1246, 1995
7. EDDY AA, GIACHELLI CM: Renal expression of genes that promote interstitial inflammation and fibrosis in rats with protein-overload proteinuria. Kidney Int 47:1546-1557, 1995
8. PICHLER RH, FRANCESCHININ N, YOUNG BA, HUGO C, ANDOH TF, BURDMANN EA, SHANKLAND SJ, ALPERS CE, BENNETT WM, COUSER WG, JOHNSON RJ: Pathogenesis of cyclosporine nephropathy: roles of angiotensin II and osteopontin. J Am Soc Nephrol 6:1186-1196, 1995
9. EDDY AA: Interstitial inflammation and fibrosis in rats with diet-induced hypercholesterolemia. Kidney Int 50:1139-1149, 1996
10. BORDER WA, OKUDA S, LANGUINO LR, SPORN MB, RUOSLAHTI E: Suppression of experimental glomerulonephritis by antiserum against transforming growth factor-β1. Nature 346:371-374, 1990
11. OKUDA S, LANGUINO LR, RUOSLAHTI E, BORDER WA: Elevated expression of transforming growth factor-β and proteoglycan production in experimental glomerulonephritis. Possible role in expansion of mesangial extracellular matrix. J Clin Invest 86:453-462, 1990
12. NOBLE NA, HARPER JR, BORDER WA: In vivo interactions of TGF-β and extracellular matrix. Progr Growth Factor Res 4:369-382, 1992
13. HOCKFIELD S, CARLSON S, EVANS C, LEVITT P: In situ hybridization, in Molecular Probes of the Nervous System, edited by PINTAR J, SILBERSTEIN L, Cold Spring Harbor, Cold Spring Harbor Laboratory Press, 1993, pp 227-262
14. HAUSSER H, OBER B, QUENTIN-HOFFMANN E, SCHMIDT B, KRESSE H: Endocytosis of different members of the small chondroitin/dermatan sulfate proteoglycan family. J Biol Chem 267:11559-11564, 1992
15. DIAMOND JR, KEES-FOLTS D, RICARDO SD, PRUZNAK A, EUFEMIO M: Early and persistent up-regulated expression of renal cortical osteopontin in experimental hydronephrosis. Am J Pathol 146:1455-1466, 1995
16. CHOMCZYNSKI P, SACCHI N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1987
17. ASUNDI VK, DREHER KL: Molecular characterization of vascular smooth muscle decorin: Deduced core protein structure and regulation of gene expression. Eur J Cell Biol 59:314-321, 1992
18. RICARDO SD, BOND JS, JOHNSON GD, KASPAR J, DIAMOND JR: Expression of subunits of the metalloendopeptidase meprin in the rat renal cortex in experimental hydronephrosis. Am J Physiol 270:F669-F676, 1996
19. COIMBRA T, WIGGINS R, NOH JW, MERRITT S, PHAN SH: Transforming growth factor-β production in anti-glomerular basement membrane disease in the rabbit. Am J Pathol 138:223-234, 1991
20. WALLENSTEIN SC, ZUCKER CL, FLEISS JL: Some statistical methods useful in circulation research. Circ Res 47:1-9, 1980
21. DIAMOND JR, VAN GOOR H, ENGLEMYER E: Myofibroblasts in experimental hydronephrosis. Am J Pathol 145:121-129, 1995
22. DING G, VAN GOOR H, DIAMOND JR: Transforming growth factor-β expression in macrophages during hypercholesterolemic states. Am J Physiol 267:F937-F943, 1994
23. BASSOLS A, MASSAGUE J: Transforming growth factor-β regulates the expression and structure of extracellular matrix chondroitin e/dermatan sulfate proteoglycans. J Biol Chem 263:3039-3045, 1988
24. BORDER WA, NOBLE NA, YAMAMOTO T, HARPER JR, YAMAGUCHI Y, PIERSCHBACHER MD, RUOSLAHTI E: Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease. Nature 360:361-364, 1992
25. HAUSSER H, GRONING A, HASILIK A, SCHONHERR E, KRESSE H: Selective inactivity of TGF-β/decorin complexes. FEBS Lett 353:243-245, 1994
26. BORDER WA, NOBLE NA: Transforming growth factor β in tissue fibrosis. N Engl J Med 331:1286-1292, 1994
27. SHARMA AK, MAUER SM, KIM Y, MICHAEL AF: Interstitial fibrosis in obstructive nephropathy. Kidney Int 44:774-788, 1993
28. BORDER WA, RUSOLAHTI E: Transforming growth factor-β. The dark side of tissue repair. J Clin Invest 90:1-7, 1992